Lawyer in Purdue Pharma case worries settlement quantity might be low

Attorney in Purdue Pharma case worries settlement amount will be low

HUNTINGTON, W. Va. West Virginia’s stake in the bankruptcy regime for pharmaceutical giant Purdue Pharma is likely to be significantly less than the West Virginia attorneys who took the company to court asked. Mike Wölfel It’s becoming increasingly clear that settlement funds in places hardest hit by the addiction problems of Oxycontin, one of the … Read more

HAGENS BERMAN Encourages Athira Pharma (ATHA) Buyers to Contact Agency’s Attorneys Now, SECURITIES FRAUD LAWSUIT FILED, Software Deadline Approaching

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts GoHealth (GOCO) Investors to November 20th Lead Plaintiff Deadline, Investors with Losses Should Contact the Firm

SAN FRANCISCO, CA / ACCESSWIRE / July 9, 2021 / Hagens Berman calls on Athira Pharma, Inc. (NASDAQ: ATHA) Investors with significant losses, file your losses now. A securities class action has been filed and certain investors may have valuable claims. School lesson: September 18, 2020 – June 17, 2021 Deadline of the main plaintiff: … Read more

WV Legal professional Common opposes multi-billion greenback settlement with Purdue Pharma

WV Attorney General opposes multi-billion dollar settlement with Purdue Pharma

CLARKSBURG, W.Va. West Virginia Attorney General Patrick Morrisey reiterated his opposition to the splitting of a multi-billion dollar deal with Purdue Pharma on Thursday. The Attorney General also welcomed the news that continued negotiations under the proposed settlement have resulted in pledges of more money and more accountability. “We still need more resources for West … Read more

Hashish Patent Litigation Replace: Cover Progress Sues GW Pharma

Cannabis Patent Litigation Update: Canopy Growth Sues GW Pharma

We have previously written on the fundamentals of cannabis patents, which is a significant area of ​​growth within the cannabis industry, and we have written extensively on cannabis trademark litigation (see some of our posts here, here, and here) has been very productive over the past few years, but we have have seen very little … Read more

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Reminds Innate Pharma S.A. Buyers of Essential December 22 Deadline in Securities Class Motion – IPHA | State

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action - IPHA | State

NEW YORK, December 15, 2020 / PRNewswire / – Rosen Law Firm, a global investor rights law firm, is reminding buyers of the securities of Innate Pharma SA (NASDAQ: IPHA) between March 10, 2020 and September 8, 2020including (the “class period”) of the important December 22, 2020 Lead plaintiff deadline in the company’s first securities … Read more

Billion-Greenback Opioid Chapter: Purdue Pharma Information for Chapter 11 as A part of Settlement

Billion-Dollar Opioid Bankruptcy: Purdue Pharma Files for Chapter 11 as Part of Settlement

Purdue Pharma, which made $ 3 billion selling drugs like the opioid oxycontin in 2017 alone, will file for bankruptcy under a possible settlement that covers hundreds of lawsuits against the company. The announcement also comes on allegations that the Sackler family – who own Purdue – used Swiss bank accounts to transfer $ 1 … Read more

California Antitrust and Tort: Ixchel Pharma v. Biogen

California Antitrust and Tort: Ixchel Pharma v. Biogen

Freitag, 11. September 2020 Am 3. August 2020 erließ der Oberste Gerichtshof von Kalifornien seine mit Spannung erwartete Entscheidung in der Rechtssache Ixchel Pharma, LLC gegen Biogen, Inc., in der die Grenzen des legitimen Wettbewerbs nach dem kalifornischen Delikts- und Kartellrecht klargestellt wurden. Die Entscheidung des Gerichtshofs wurde im Allgemeinen zugunsten der Förderung des Wettbewerbs, … Read more